ABIONYX Pharma Provides an Update on Its Activity and Cash Position for the 1st Quarter 2024 finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
ABIONYX Pharma Provides an Update on Its Activity and Cash Position for the 4th Quarter 2023 finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
ABIONYX Pharma Provides an Update on Its Business and Cash Position for the First Half of 2023 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
ABIONYX Pharma Announces a New Compassionate Access Authorization (CAA) for CER-001 in the Rare Disease LCAT Deficiency or Norum Disease in Europe finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
ABIONYX Pharma announced that the company has been granted a new Compassionate Access Authorization in Europe for CER-001 in the rare, untreated kidney disease LCAT Deficiency. This is the fourth.